UnitedHealth Raises Quarterly Dividend 5.0% to $2.32

UnitedHealth Group Incorporated raised its quarterly dividend 5.0% to $2.32 a share from $2.21, setting the annual dividend at $9.28. The increased payment traded ex-dividend on June 15, 2026. The move extends the health insurer’s dividend-growth streak to 16 consecutive years.

Why the dividend changed

The board’s declaration gave the amount but no event-specific explanation. UnitedHealth has said its dividend policy weighs long-term earnings and cash flow, the outlook for its businesses, capital and liquidity requirements, investment and acquisition opportunities, market conditions and capital-return practices among peers. The board approved the increased payment at its regular quarterly meeting, alongside the company’s annual shareholder meeting update. UnitedHealth’s board announcement confirmed the authorization without tying it to a split, merger, spinoff or special transaction.

Management had already told investors that it expected the dividend to remain “well supported by earnings and cash flow” in 2026. It also expected cash generation and a more stable operating environment to reduce leverage and support a return to its historical capital-deployment practices during the second half of the year. Management’s fourth-quarter remarks provide the clearest explanation for the board’s capacity to raise the payment.

The increase followed a difficult 2025 marked by Medicare funding pressure and elevated medical costs at Optum Health. First-quarter 2026 results showed revenue of $111.7 billion, operating earnings of $9.0 billion and $8.9 billion of operating cash flow, equal to 1.4 times net income. UnitedHealth also raised its full-year adjusted earnings outlook to greater than $18.25 a share. UnitedHealthcare benefited from repricing, although utilization and unit-cost trends remained elevated, while operational improvements partly offset continued medical-cost pressure at Optum Health. The first-quarter report therefore supports reading the dividend decision as a measured response to improving operations and cash generation.

Dividend track record

Recent payments show a consistent midyear step-up. UnitedHealth paid $2.10 on the March 10, 2025, ex-dividend date, increased the rate to $2.21 beginning June 16, 2025, and held that amount through March 9, 2026. The rate then advanced to $2.32 for the June 15, 2026, and September 14, 2026, ex-dividend dates.

The annual total climbed from $4.83 in 2020 to $8.73 in 2025. The pace moderated along the way: annual growth was 15.9% in 2021, 14.3% in 2022, 13.9% in 2023, 12.2% in 2024 and 6.7% in 2025. The latest 5.0% increase is also below the five-year rate of 12.1% annual growth. That pattern points to continued dividend expansion at a more conservative pace following several years of double-digit increases.

UnitedHealth has now raised its dividend for 16 consecutive years. Its last annual cut occurred in 1999, placing the current streak well beyond the company’s transition through multiple economic and health-care cycles. The company’s dividend history confirms the recent sequence of quarterly payments.

Is the dividend covered?

The dividend consumes 58% of earnings. That places more than half of reported profit into shareholder distributions but retains a meaningful buffer between earnings and the payment obligation.

SmarterDividends rates the dividend A with a safety score of 88, classified as very safe within the score range of 80-100. In plain terms, the earnings coverage, long growth record and recent operating cash generation provide substantial support for the current rate. The grade does not eliminate risks from medical-cost trends, regulatory actions, leverage or deterioration in the underlying businesses.

Yield and valuation

At a share price of $371.02, UnitedHealth’s forward yield is 2.50%, compared with a 1.80% median for the Healthcare sector. The shares therefore provide a higher forward income rate than the sector benchmark, although the market yield will move as the share price changes.

SmarterDividends estimates fair value at $603.89 and classifies the shares as undervalued, representing 60% upside to fair value. That estimate is a valuation reference based on current inputs, not a price target or forecast.

What to watch

The next operating checkpoint following the increase was the second-quarter report scheduled for July 16, 2026. The central items were operating cash flow, medical-cost trends, UnitedHealthcare’s repricing progress and whether Optum Health’s operational improvements continued to offset elevated costs.

Capital allocation also warrants attention. UnitedHealth expected leverage to move toward its long-term target during the second half of 2026 and said it planned to resume historical capital-deployment practices as that occurred. Separately, the company had agreed to acquire benefits-administration platform Alegeus Technologies, subject to regulatory review, with closing expected in the second half of 2026. It also expected to complete at least $2.0 billion of share repurchases by the end of the second quarter. Those commitments provide concrete tests of how management balances acquisitions, debt reduction, buybacks and the quarterly dividend.